Head to Head Analysis: Nyxoah (NASDAQ:NYXH) vs. Establishment Labs (NASDAQ:ESTA)

Nyxoah (NASDAQ:NYXH) and Establishment Labs (NASDAQ:ESTA) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, earnings, dividends and risk.

Volatility and Risk

Nyxoah has a beta of 1.63, meaning that its stock price is 63% more volatile than the S&P 500. Comparatively, Establishment Labs has a beta of 1.05, meaning that its stock price is 5% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of current ratings for Nyxoah and Establishment Labs, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nyxoah	1	1	2	0	2.25
Establishment Labs	1	0	8	0	2.78

Nyxoah currently has a consensus price target of $4.26, suggesting a potential upside of 182.25%. Establishment Labs has a consensus price target of $100.25, suggesting a potential upside of 33.81%. Given Nyxoah’s higher probable upside, equities research analysts clearly believe Nyxoah is more favorable than Establishment Labs.

Valuation & Earnings

This table compares Nyxoah and Establishment Labs”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nyxoah	$21.66 million	2.70	-$101.92 million	($2.52)	-0.60
Establishment Labs	$211.08 million	10.58	-$51.06 million	($1.31)	-57.19

Establishment Labs has higher revenue and earnings than Nyxoah. Establishment Labs is trading at a lower price-to-earnings ratio than Nyxoah, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

72.9% of Establishment Labs shares are held by institutional investors. 17.1% of Nyxoah shares are held by insiders. Comparatively, 10.0% of Establishment Labs shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Nyxoah and Establishment Labs’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nyxoah	-443.16%	-178.90%	-81.83%
Establishment Labs	-15.82%	-196.69%	-10.73%

Summary

Establishment Labs beats Nyxoah on 9 of the 14 factors compared between the two stocks.

About Nyxoah

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

About Establishment Labs

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.